aciclovir claris 25 mg/ml concentrate for soln for inf
claris lifesciences (uk) limited - aciclovir - concentrate for soln for inf - 25 mg/ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors
ondansetron-claris
claris lifesciences australia pty ltd - ondansetron hydrochloride dihydrate -
fluconazole 2 mg/ml solution for infusion
claris lifesciences (uk) limited - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole
fluconazole
claris lifesciences (uk) limited - fluconazole - solution for infusion - 2 mg/ml - fluconazole
fluconazole-claris
claris lifesciences australia pty ltd - fluconazole -
metronidazole-claris
claris lifesciences australia pty ltd - metronidazole -
bupivacaine 2.5 mg/ml solution for injection
claris lifesciences (uk) limited - bupivacaine hydrochloride - solution for injection - 2.5 mg/ml - amides
bupivacaine 5.0 mg/ml solution for injection
claris lifesciences (uk) limited - bupivacaine hydrochloride - solution for injection - 5.0 mg/ml - amides
mesna-claris mesna 200 mg/2 ml solution for injection ampoule
baxter healthcare pty ltd - mesna, quantity: 100 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections; nitrogen; sodium hydroxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide and ifosfamide product information).
mesna-claris mesna 400 mg/4 ml solution for injection ampoule
baxter healthcare pty ltd - mesna, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; nitrogen; water for injections; disodium edetate - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide and ifosfamide product information).